Generation and molecular characterization of multiple human neural cell types
Generation and molecular characterization of multiple human neural cell types
批准号:
9913464
负责人:
Zhexing Wen
金额:
$14.97万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
3-DimensionalAddressAstrocytesBioinformaticsBiologicalBiopsyBrainCaribbean regionCell Culture TechniquesCell Differentiation processCell LineCell modelCellsCentral Nervous System InfectionsCerebrumCountryCoupledDataData SetDevelopmentDiseaseDocumentationEncephalitisEngineeringEnsureFeedbackFibroblastsFlavivirusFlavivirus InfectionsFloridaGenerationsGuillain-Barré SyndromeHumanHuman DevelopmentHuman ResourcesHuman bodyInterneuronsLatin AmericaLeadLinkMeningitisMethodologyMicrocephalyModelingMolecularNeurologicNeuronsNewborn InfantOrganoidsOutcomePathogenesisPathologicPathologyPatientsPlayPopulationProcessProsencephalonProtocols documentationRNA analysisReportingReproducibilityResearchResourcesRoleShipsSiteSkinStandardizationTechnologyTimeTissuesTrainingUniversitiesValidationVariantVirus DiseasesWest Nile viral infectionWest Nile virusWorkZIKV infectionZika Virusbasebrain abnormalitiesbrain tissuecell typecomputerized data processingdisease phenotypedrug developmentdrug discoveryexperimental studyhuman diseasehuman tissueimpaired brain developmentin vitro Modelinduced pluripotent stem cellinfectious disease modelmembermosquito-bornenerve stem cellneurodevelopmentneurotropic virusnovel strategiesorgan growthsingle-cell RNA sequencingstem cell biologytechnology developmenttranscriptome sequencingtranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY – Scientific Core
Human induced pluripotent stem cells (iPSCs) offer a remarkable opportunity to study human tissue and
organ development and to discover the molecular and cellular basis of human diseases. Capable of being
differentiated into nearly any cell type in the human body, iPSCs have proven to be invaluable for studying
previously inaccessible cell populations such as neural cells of the developing and mature brain. These
populations are among the most relevant cell types in the study of neurotropic viruses such as Zika virus
(ZIKV) and West Nile virus (WNV).
ZIKV, a mosquito-borne flavivirus, is currently reported to be circulating in 26 countries and territories in
Latin America and the Caribbean. While ZIKV infection has been linked to microcephaly in newborns and other
brain abnormalities such as Guillain-Barré syndrome, how ZIKV impairs brain development and function is
unknown. WNV, another member of flavivirus genus, can also lead to serious neurologic illnesses such as
encephalitis or meningitis, with the underlying mechanism remains elusive and there is no reported studies
using human cellular models. Since access to human brain tissue is very limited, generating new cellular
models using human iPSCs can facilitate biological discovery and drug development. Recently developed
technology to generate 3D cerebral organoids from iPSCs holds the promise of allowing for more accurate
models that recapitulate key processes and features of human brain development. To model ZIKV and WNV
infections of the central nervous system, the Scientific Core will optimize and standardize protocols for
differentiation of disease-relevant specific cell types (Specific Aims 1 and 2), generate genetically-modified
iPSC lines for functional studies (Specific Aim 1), supply cells and provide on-site training for all projects
(Specific Aim 2), and perform bioinformatics analyses for transcriptomic profiling (Specific Aim 3). The
Scientific Core plays an essential role in setting standards for reproducible conditions for cell culture through
cross-training of personnel in Projects 2 & 3, which is a critical component of robust platform development. The
Scientific Core will work closely with Project 1 on technology development and protocol optimization and the
Administrative Core for documentation and dissemination of validated protocols.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Towards a Better Understanding of Fragile X Syndrome Using Human Brain Organoids
-
批准号:10038026
-
项目类别:
-
资助金额:$42.9万
-
财政年份:2020
-
负责人:Zhexing Wen
-
依托单位:
海外基金